Work

Outcomes of switching from Adalimumab biosimilar MSB11022 to Adalimumab biosimilar GP2017 in patients with rheumatoid diseases

Year: 2024

Type: book-chapter

Source: Sociedad Española de Farmacia Hospitalaria eBooks

DOI: 10.62917/24.69.0519

Authors: Joaquín Borrás Blasco, SILVIA CORNEJO UIXEDA, MARTA AGUILAR ZAMORA, MARTA GARIJO BUFORT, CELIA APARICIO RUBIO

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400488152

FWCI:

Cites:

Cited by:

Related to: 10